Read Financial Articles on Day Trading, Investment, Stock Market, NIFTY, BSE, NSE, Mutual Fund, Commodities and ETF
JACKPOT PACKAGE: Get 95%+ Accuracy in our premium package. Charges only Rs.5000/Month.
To Get Free Trial Just SMS JACKPOT and your Name to 9999961207 or Call Us.
Share Gyan launches new website for COMMODITY TIPS. Register for free trial @ CommodityGyan.in now!


News Tagged as ‘Sun Pharmaceutical’

Sun Pharmacy positive on US market

Thursday, September 17, 2009 12:01 pm No Comments

Sun Pharmaceutical Industries is positive on the US market in spite of going through crisis with US Food and Drug Administration.

By ShareGyan.com NewsDesk Tags: ,

Sun Pharmacy trades down

Thursday, July 30, 2009 12:29 pm No Comments

89,234shares traded on BSE in the counter as opposed to a standard everyday volume of 56226shares in the last single quarter.

By ShareGyan.com NewsDesk Tags: , , , ,

Sun Pharmacy swings low

Wednesday, July 29, 2009 3:06 pm No Comments

45480shares have been traded on BSE in the counter as opposed to a standard everyday volume of 56,226 shares in the last single quarter.

By ShareGyan.com NewsDesk Tags: , , ,

Sun Pharmaceuticals introduces new discussions with Taro promoters

Monday, March 23, 2009 10:00 am No Comments

Sun Pharmaceuticals has commenced new discussions with advertisers Levitt and Moros and other shareholders.

By ShareGyan.com NewsDesk Tags: ,

Sun Pharma trades in the positive zone

Tuesday, February 3, 2009 1:10 pm No Comments

Sun Pharmaceutical Industries presently trades at Rs.1,049, which is up from its earlier closing of Rs.1,046.35 on the Sensex.

By ShareGyan.com NewsDesk Tags: , , , ,

Copyright © 2009 ShareGyan.com. All rights reserved.

Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. ShareGyan.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure: The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.